KU0058948 [Ligand Id: 13125] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL380648 (KU-0058948)
  • poly(ADP-ribose) polymerase 1/Poly [ADP-ribose] polymerase-1 in Human [ChEMBL: CHEMBL3105] [GtoPdb: 2771] [UniProtKB: P09874]
There should be some charts here, you may need to enable JavaScript!
  • poly (ADP-ribose) polymerase 3/Poly [ADP-ribose] polymerase 3 in Human [ChEMBL: CHEMBL5083] [GtoPdb: 2864] [UniProtKB: Q9Y6F1]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
poly(ADP-ribose) polymerase 1/Poly [ADP-ribose] polymerase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3105] [GtoPdb: 2771] [UniProtKB: P09874]
GtoPdb Binding affinity determined by isothermal titration calorimetry. - 7.72 pKd 19 nM Kd J Med Chem (2009) 52: 3108-11 [PMID:19354255]
ChEMBL Binding affinity to human PARP1 by isothermal titration colorimetry B 7.72 pKd 19 nM Kd J Med Chem (2009) 52: 3108-3111 [PMID:19354255]
ChEMBL Inhibitory activity against PARP1 B 8.15 pIC50 7 nM IC50 Bioorg Med Chem Lett (2006) 16: 1040-1044 [PMID:16290932]
ChEMBL Inhibition of PARP1 by flashplate scintillation proximity assay B 8.15 pIC50 7 nM IC50 J Med Chem (2008) 51: 6581-6591 [PMID:18800822]
ChEMBL Inhibition of human PARP1 B 8.47 pIC50 3.4 nM IC50 J Med Chem (2009) 52: 3108-3111 [PMID:19354255]
poly (ADP-ribose) polymerase 3/Poly [ADP-ribose] polymerase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5083] [GtoPdb: 2864] [UniProtKB: Q9Y6F1]
GtoPdb Binding affinity for PARP3 catalytic domain (178−532) determined by isothermal titration calorimetry. - 7.15 pKd 70 nM Kd J Med Chem (2009) 52: 3108-11 [PMID:19354255]
ChEMBL Binding affinity to human PARP3 PARP domain by isothermal titration colorimetry B 7.15 pKd 70 nM Kd J Med Chem (2009) 52: 3108-3111 [PMID:19354255]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]